Abstract. Cyperus rotundus L. belongs to the Cyperaceae family and is a well documented traditional medicinal herb. Its rhizome has been reported to possess wide spectrum pharmacological activities including anti-inflammatory and antioxidant activity. However, the cellular and molecular mechanisms of the anticancer activity have not been elucidated. In the present study, we investigated the pro-apoptotic effects of C. rotundu rhizomes in a human breast carcinoma MDA-MB-231 cell model. Treatment of MDA-MB-231 cells with an ethanol extract of C. rotundu rhizomes (EECR) and a methanol extract of C. rotundu rhizomes (MECR), but not a water extract of C. rotundu rhizomes, resulted in potent antiproliferative activity. The activity of the EECR was higher than that of the MECR and was associated with the induction of apoptosis. The induction of apoptosis by the EECR was associated with upregulation of death receptor 4 (DR4), DR5 and pro-apoptotic Bax, as well as downregulation of anti-apoptotic survivin and Bcl-2. EECR treatment also downregulated Bid expression and activated caspase-8 and -9, the respective initiator caspases of the extrinsic and intrinsic apoptotic pathways. The increase in mitochondrial membrane depolarization was correlated with activation of effector caspase-3 and cleavage of poly(ADP-ribose) polymerase, a vital substrate of activated caspase-3. Blockage of caspase activation by pretreatment with a pan-caspase inhibitor consistently inhibited apoptosis and abrogated growth inhibition in EECR-treated MDA-MB-231 cells. Although reactive oxygen species (ROS) increased following treatment with the EECR, inhibiting ROS with a ROS scavenger did not attenuate EECR-induced apoptosis. Furthermore, inhibitors of phosphatidylinositol 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK) signaling pathways failed to reverse EECR-induced apoptosis and growth inhibition. These results suggest that the pro-apoptotic activity of the EECR may be regulated by a caspase-dependent cascade through activation of both intrinsic and extrinsic signaling pathways that is not associated with ROS generation or the PI3K/Akt and MAPK pathways.
Introduction
Breast cancer is the most common type of non-skin human malignancy and the second leading cause of cancer-related mortality among women in Western countries, accounting for 23% of total cancer cases and 14% of cancer-related deaths. The incidence of breast cancer is the highest in North America and Europe and the lowest in Asia. However, the incidence of and mortality from breast cancer in poorly developed countries are expected to increase considering the trend in westernization of living (1, 2) . Although several etiological factors are associated with the occurrence of breast cancer, type of diet, hormone-associated reproductive factors, obesity and atypical hyperplasia of the mammary gland are the most prevalent. Approximately 50% of breast cancers arise in the absence of known common risk factors, and surgery remains the primary treatment with chemotherapy and radiotherapy used as adjuvants (3, 4) . Despite the extensive use of multimodal
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Cyperus rotundus L. by activating caspases therapies, breast cancer remains the leading cause of cancerrelated mortality among women in the world, emphasizing the need for novel therapeutic approaches. To overcome these challenges, novel therapeutic strategies are required for more effective treatment of this serious disease. Apoptosis, or programmed cell death, is an essential tool for the body to eliminate excess, damaged or harmful cells. In general, cells undergo apoptosis through the extrinsic (death receptor-mediated) and intrinsic (mitochondrial-mediated) pathways (5, 6) . The extrinsic pathway is triggered by binding of the cell surface death receptors with their relevant ligands, which leads to activation of caspase-8 and/or -10. During the intrinsic apoptotic pathway, internal and external stressors lead to the release of apoptogenic proteins from the mitochondria, which along with Apaf-1, activate caspase-9. Caspase-8, -9 and -10 are the initiator caspases, as they initiate activation of the effector caspase-3 and -7, triggering the apoptotic caspase cascade (6, 7) . Caspase-8 alone is sufficient in some cases to activate caspase-3 in response to receptor-mediated apoptotic stimuli, however caspase-8 requires the assistance of the intrinsic apoptotic pathway for enhancing apoptotic stimuli. This can be achieved through caspase-8-mediated proteolytic activation of the pro-apoptotic Bcl-2 homology domain (BH)3-only protein BH3-interacting domain death agonist (Bid), which then causes mitochondrial outer membrane permeabilization and leads to mitochondrial release of apoptogenic proteins including cytochrome c (8, 9) . During the past decade, accumulating evidence has suggested that many cancer therapeutic agents induce apoptosis. Although the anticancer agent mechanisms of the apoptotic pathway are controversial, the killing of cancer cells through the induction of apoptosis has been recognized as a novel strategy for identifying chemotherapeutic as well as chemopreventive agents (10) (11) (12) .
Cyperus rotundus Linn, a sedge in the Cyperaceae family, is a well documented medicinal herb, with a worldwide distribution in tropical and temperate regions. The tuber part of C. rotundus is a commonly used traditional Oriental medicine for treatment of dysmenorrhea and other menstrual irregularities. This herb is also widely used as an analgesic, nerve tonic, nootropic, sedative, anti-spasmodic, anti-malarial, antidiarrheal and a reliever of stomach disorders (13) (14) (15) (16) (17) . Previous pharmacological investigations indicated that the extracts and/ or components of C. rotundus rhizomes have marked hypotensive, anti-mutagenic, anti-obese, neuroprotective, antioxidant, anti-inflammatory and anti-pyretic effects (18) (19) (20) (21) (22) (23) (24) (25) (26) . In addition, this herb is often prescribed in combination with other herbs to treat stomach ache, inflammation and peptic ulcer disease (27, 28) . However, despite its valuable effects, little is known about the biochemical basis of the anticancer potential of C. rotundus. In the present study, as part of our search for novel biologically active substances to prevent and treat cancer from traditional medicinal resources, we evaluated whether the extracts of C. rotundus rhizomes could inhibit cell growth and trigger apoptosis in human breast carcinoma cells.
Materials and methods
Reagents and antibodies. Fetal bovine serum (FBS), Dulbecco's modified Eagle's medium (DMEM), penicillin, streptomycin and trypsin-ethylenediaminetetraacetic acid (EDTA) were purchased from Gibco-BRL (Gaithersburg, MD, USA). 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), trypan blue, 4,6-diamidino-2-phenyllindile (DAPI), propidium iodide (PI), paraformaldehyde, 5,5',6,6' -tetrachloro-1,1',3,3'-tetraethyl-imidacarbocyanine iodide (JC-1) and N-acetyl L-cysteine (NAC) were purchased from Sigma-Aldrich (St. Louis, MO, USA). The pan-caspase inhibitor z-VAD-fmk and inhibitors of phosphatidylinositol 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK) were obtained from Calbiochem (San Diego, CA, USA). DNA ladder size markers were purchased from Invitrogen (Carlsbad, CA, USA). 2',7'-Dichlorofluorescein diacetate (DCFDA) and fluorescein-isothiocyanate (FITC)-Annexin V were purchased from Molecular Probes (Eugene, OR, USA) and BD Pharmingen (San Diego, CA, USA), respectively. Caspase activity assay kits and an enhanced chemiluminescence (ECL) kit were purchased from R&D Systems (Minneapolis, MN, USA) and Amersham (Arlington Heights, IL, USA), respectively. Antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), Chemicon (Temecula, CA, USA) and Sigma-Aldrich. Peroxidase-labeled donkey anti-rabbit and sheep anti-mouse immunoglobulin were purchased from Amersham. All other chemicals were purchased from Sigma-Aldrich.
Preparation of C. rotundus rhizome extracts. C. rotundus rhizomes were obtained from the Dongeui Oriental Hospital, Dongeui University College of Oriental Medicine, Busan, Republic of Korea. They were cut into small pieces, ground to powder, passed through a 20-mesh sieve, and transferred to a flask in a 1:10 proportion (drug: solvent, w/v), using methanol, ethanol and water. The materials were protected from light with aluminum foil, and the flasks were shaken at 50 rpm for 24 h at 60˚C. The extracts were filtered through Whatman paper no. 1 and dried in a Rotavapor at 40˚C, resulting in methanol (MECR), ethanol (EECR) and water (WECR) extracts. The extracts were weighed, resuspended into dimethyl sulfoxide to a final concentration of 100 mg/ml (extract stock solution) and then diluted with medium to the desired concentration prior to use.
Cell culture. The MDA-MB-231 human breast carcinoma cell line was purchased from the American Type Culture Collection (Manassas, VA, USA) and maintained in DMEM supplemented with 10% FBS, 1% L-glutamine and penicillin/streptomycin. The cells were cultured in an incubator with 5% CO 2 at 37˚C.
Cell growth and cell viability assay. Cell growth was assessed using the trypan blue dye exclusion assay. In brief, cells (2x10 4 cells/well) were seeded in 6-well plates. After treatment with the indicated concentrations of the C. rotundus extracts for 24 h, the cells were trypsinized and viable cells were counted by trypan blue dye exclusion using a hemocytometer under an inverted microscope (Carl Zeiss, Jena, Germany). Cell viability was determined using the MTT assay. In brief, cells (2x10 4 cells/well) were seeded in 24-well plates and exposed to the extracts of C. rotundus for 24 h. After treatment, 5 mg/ml MTT solution was added, followed by a 3-h incubation at 37˚C in the dark. Absorbance of the formazan product was measured at a wavelength of 540 nm with an enzyme-linked immunosorbent assay (ELISA) reader (Molecular Devices, Sunnyvale, CA, USA). Cells were photographed directly for a morphological study using an inverted microscope.
DAPI nuclear staining. The cells were washed with phosphatebuffered saline (PBS) and fixed with 3.7% paraformaldehyde in PBS for 10 min at room temperature. The fixed cells were permeabilized with 0.1% Triton x-100 for 10 min, the supernatant was removed and the cells were washed three times with PBS. The cells were incubated with 2.5 µg/ml DAPI for 10 min at room temperature in the dark. The cells were then washed twice with PBS and DAPI-stained cell nuclei (apoptotic nuclei stained intensely) and were observed with a fluorescence microscope (Carl Zeiss).
Agarose gel electrophoresis. Cells were lysed in a buffer containing 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA and 0.5% Triton x-100 for 1 h at room temperature for the DNA fragmentation assay. Lysates were vortexed and cleared by centrifugation at 19,000 x g for 30 min at 4˚C. A 25:24:1 (v/v/v) equal volume of neutral phenol:chloroform:isoamyl alcohol was used to extract DNA from the supernatant, followed by electrophoretic analysis on 1.5% agarose gels containing 0.1 µg/ml ethidium bromide. Protein extraction and western blot analysis. The cells were collected by trypsin-EDTA and lysed with lysis buffer (20 mM sucrose, 1 mM EDTA, 20 µM Tris-Cl, pH 7.2, 1 mM DTT, 10 mM KCl, 1.5 mM MgCl 2 , 5 µg/ml pepstatin A, 10 µg/ml leupeptin and 2 µg/ml aprotinin) containing protease inhibitors for 30 min at 4˚C. The mixtures were centrifuged (10,000 x g) for 10 min at 4˚C, and the supernatants were collected as whole-cell extracts. Protein content was determined using the Bio-Rad protein assay reagent (Hercules, CA, USA) and bovine serum albumin as the standard according to the manufacturer's instructions to determine protein concentrations. After normalization, an equal amount of protein was subjected to electrophoresis on sodium dodecyl sulfate-polyacrylamide gels and transferred to nitrocellulose membranes (Schleicher & Schuell, Keene, NH, USA) by electroblotting. The blots were blocked with 5% skim milk for 1 h at room temperature. The blots were incubated overnight with primary antibodies, followed by horseradish peroxidase-conjugated donkey antirabbit and sheep anti-mouse immunoglobulin for 1 h. The immunoreactive bands were revealed by enhanced chemiluminescence with a commercially available ECL kit.
Measurement of mitochondrial membrane potential (MMP).
MMP values were determined using the dual-emission potential-sensitive probe, JC-1. Briefly, cells were collected and incubated with 10 µM JC-1 for 30 min at 37˚C in the dark. After JC-1 was removed, the cells were washed with PBS to remove unbound dye, and the amount of JC-1 retained by 10,000 cells/sample was measured at 488 and 575 nm using a flow cytometer.
Caspase activity assay. Caspase activities were determined with colorimetric assay kits, which utilize synthetic tetrapeptides [Asp-Glu-Val-Asp (DEAD) for caspase-3, Ile-Glu-Thr-Asp (IETD) for caspase-8 and Leu-Glu-His-Asp (LEHD) for caspase-9] labeled with p-nitroaniline (pNA). Briefly, EECR-treated and untreated cells were lysed in the supplied lysis buffer. The supernatants were collected and incubated with the supplied reaction buffer containing dithiothreitol and DEAD-pNA, IETD-pNA or LEHD-pNA as substrates at 37˚C. The reactions were measured by changes in absorbance at 405 nm using an ELISA reader.
Measurement of reactive oxygen species (ROS)
. ROS production was monitored using the stable nonpolar dye DCFDA. The cells were seeded at a density of 1x10 5 cells/ml, allowed to attach for 24 h and exposed to 200 µg EECR for various periods. The cells were incubated with 10 mM DCFDA for 20 min at 37˚C in the dark. ROS production in the cells was monitored with a flow cytometer using CellQuest Pro software.
Statistical analysis. Data are reported as means ± standard deviation of three independent experiments. A one-way analysis of variance was performed to determine differences. p<0.05 was considered to indicate a statistically significant difference.
Results

Antiproliferative activity of C. rotundus rhizome extracts in MDA-MB-231 cells.
To investigate the effects of C. rotundus rhizome extracts on MDA-MB-231 cell growth, the cells were treated with various concentrations of the MECR, EECR and WECR for 24 h, and cell number and viability were measured by trypan blue exclusion and the MTT assay, respectively. As shown in Fig. 1 , the MECR and EECR markedly inhibited cell proliferation and viability of MDA-MB-231 cells in a concentration-dependent manner. For example, cell viability was inhibited by >30 or 65% in cells exposed to 150 or 300 µg/ml of the EECR, respectively, compared to that in untreated controls. In contrast, the WECR was not cytotoxic under the same experimental conditions. The EECR possessed stronger cytotoxicity than MECR; thus, we used the EECR for further studies.
Induction of apoptosis in MDA-MB-231 cells by EECR treatment.
Cell morphology was assessed by DAPI staining. The results indicated that the nuclear structure of control cells remained intact, whereas nuclear chromatin condensation and fragmentation, characteristics of apoptosis, were observed in cells treated with the EECR and were associated with numerous cellular morphological changes ( Fig. 2A and B) .
In particular, cell shrinkage and cytoplasm condensation appeared in a dose-dependent manner after EECR treatment. In addition, treatment with the EECR induced progressive accumulation of fragmented DNA, which appeared as a typical ladder pattern of DNA fragmentation due to internucleosomal cleavage associated with apoptosis, in a concentration-dependent manner (Fig. 2C) . Furthermore, we evaluated apoptotic induction by flow cytometry analysis with Annexin V and PI staining. As shown in Fig. 2D , treatment with the EECR resulted in an increased accumulation of apoptotic cells compared with that of untreated control cells.
Effects of EECR treatment on expression of apoptosis-related genes.
The death receptor and corresponding pro-apoptotic ligands were examined by western blot analysis to determine which apoptosis pathway contributes to EECR-induced apoptosis. The results showed that the levels of TRAIL, Fas and FasL expression were relatively unchanged in response to EECR treatment; however, the levels of death receptor (DR) 4 and DR5 markedly increased in response to EECR treatment (Fig. 3) . Next, we examined the effects of the EECR on the levels of Bcl-2 family proteins. The results of immunoblotting revealed downregulation of anti-apoptotic Bcl-2, but not Bcl-xL, in MDA-MB-231 cells (Fig. 3) . However, treatment with the EECR caused a marked increase in pro-apoptotic Bax expression, but not Bad. In addition, relative protein expression of anti-apoptotic survivin decreased in a concentration-dependent manner compared to that in control cells, whereas expression of xIAP, cIAP-1 and cIAP-2 was relatively constant in EECR-treated MDA-MB-231 cells (Fig. 3) .
Activation of caspases and degradation of poly(ADP-ribose) polymerase (PARP) by EECR treatment.
We next examined the effect of the EECR on caspase activity to determine whether caspase activation occurs during EECR-induced apoptosis. Fig. 4A shows that treatment of MDA-MB-231 cells with the EECR decreased pro-caspase-8 and -9 levels, which are initiator caspases of the extrinsic and intrinsic apoptotic pathways, respectively. In conjunction with the decrease in pro-caspase-8 and -9 expression, western blotting revealed were separated on SDS-polyacrylamide gels and transferred to nitrocellulose membranes. The membranes were probed with the indicated antibodies and the proteins were visualized using an enhanced chemiluminescent detection system. Actin was used as the internal control.
that EECR treatment of MDA-MB-231 cells also resulted in the downregulation of pro-caspase-3. Furthermore, activation of caspases by the EECR was confirmed by measuring enzyme activity using the specific synthetic substrates for each caspase. As indicated in Fig. 4B , we observed a dose-dependent gradual increase in caspase-3, -8 and -9 activities in EECR-treated MDA-MB-231 cells similar to the proteolytic processing of pro-caspases. Activation of caspase-3 was further evidenced from cleavage of PARP from a 116 kDa band to a 89 kDa fragment, a substrate of active caspase-3, which also serves as a marker of cells undergoing apoptosis (30) .
Effects of the EECR on apoptosis induction for mitochondrial signaling.
Since the EECR activated caspase-9, we investigated whether it would affect EECR-induced apoptosis associated with mitochondrial signaling. Thus, we examined the effects of the EECR on mitochondrial membrane integrity, one of the early events leading to apoptosis, using the JC-1 fluorescent probe. The results in Fig. 4C indicate that treatment with the EECR clearly elicited dissipation of the MMP when compared to that in control cells. The extrinsic apoptotic signaling cascade starts with activation of caspase-8 and truncation of Bid (tBid), a BH3 pro-apoptotic protein, which translocates to the mitochondrial membrane, allowing activation of pro-apoptotic proteins (8, 9) . Therefore, we further examined the effect of the EECR on the level of Bid. As indicated in Fig. 3 , EECR treatment caused a decrease in the amount of the Bid pro-form, which is indirect evidence of protein truncation and activation, suggesting that EECR-induced apoptosis in MDA-MB-231 cells may occur via activation of caspase-8 and Bid truncation.
Inhibition of EECR-induced apoptosis by a caspase inhibitor.
To further confirm the significance of caspase activation in EECR-induced apoptosis, we examined the effects of the general caspase inhibitor, z-VAD-fmk. As shown in Fig. 5A and B, pre-treatment with z-VAD-fmk completely abrogated the appearance of cells with apoptotic features, such as chromatin condensation and formation of apoptotic bodies, and attenuated the accumulation of fragmented DNA. A flow cytometric analysis and MTT assay indicated that pretreatment of cells with z-VAD-fmk prevented EECR-induced accumulation of apoptotic cell population and growth inhibition ( Fig. 5C and D) . These results show that EECR-induced apoptosis in MDA-MB-231 cells occurred via a caspase-dependent pathway.
EECR-induced apoptosis is independent of ROS generation in MDA-MB-231 cells.
Oxidative stress occurs due to an imbalance in pro-oxidant and antioxidant levels in cells. Excess ROS generation through an imbalance between pro-oxidants and antioxidants leads to damage of cellular macromolecules including DNA, proteins and lipids, and eventually results in physical and chemical damage to tissues that may lead to cell death (31, 32) . Therefore, we investigated whether ROS generation was also involved in EECR-induced apoptosis. As shown in Fig. 6A , the EECR markedly increased intracellular ROS levels within 15 min, and pretreatment with NAC, a well known ROS scavenger, markedly attenuated EECR-induced ROS generation. However, pretreatment with NAC did not block EECR-induced apoptotic morphological changes or DNA fragmentation (Fig. 6B and C) . Moreover, NAC did not inhibit EECR-induced apoptosis and growth inhibition ( Fig. 6D and E) . Collectively, these results clearly indicate that the EECR-induced apoptosis in MDA-MB-231 cells is not mediated by ROS generation.
Activation of Akt and MAPKs is not involved in EECR-induced apoptosis in MDA-MB-231 cells.
Next, we investigated the effect of EECR treatment on the expression and activities of PI3K/Akt and MAPKs to determine whether these signaling pathways play a role in mediating the observed apoptotic response. Western blot analysis showed that total Akt protein and phosphorylated Akt levels did not change significantly in response to EECR treatment. In addition, the EECR did not lead to phosphorylation of the three MAPKs including extracellular signal-regulated kinase (ERK), p38 MAPK and c-Jun NH2-terminal kinase (JNK) (Fig. 7) , and there was also no effect on steady-state levels of total MAPK proteins in MDA-MB-231 cells treated with EECR. Moreover, pretreatment with a representative PI3K/Akt inhibitor, LY294002 and inhibitors of MAPKs (PD98059, a potent inhibitor of ERK; SP600125, a potent inhibitor of JNK; SB203589, a specific inhibitor of the p38 MAPK) did not have a significant effect on EECR treatment (Fig. 8) . Collectively, these results suggest that the PI3K/Akt and MAPK pathways did not play a role in regulating EECR-induced apoptosis of MDA-MB-231 cells.
Discussion
Although the extracts and components isolated from C. rotundus possess a wide range of biological activities that may contribute to health beneficial effects, the mechanisms of the antiproliferative actions on malignant cell growth have not yet been elucidated. In our search for new natural sources of apoptosis-inducing agents from traditional medicinal plants, we studied the efficiency of extracts from C. rotundus. In the present study, using the MDA-MB-231 human breast cancer cell line, we demonstrated inhibited cell growth and viability by the EECR and the MECR as well as changes in cell morphology in a concentration-dependent manner (Figs. 1 and 2A) . To further confirm that the EECR-induced antiproliferative effects were related to apoptotic cell death, induction of apoptosis by the EECR was confirmed by measuring nuclear chromatin condensation, DNA fragmentation and accumulation of apoptotic cells (Fig. 2B-D) . Dysregulated apoptosis induces a number of pathological conditions, including cancer, and failure of apoptosis leads to an imbalance in cell number, which in turn leads to tumorigenesis. Therefore, induction of apoptosis in malignant cells has emerged as an important strategy for cancer therapy (5, 6) . Our data demonstrated that EECR-induced apoptosis was associated with induction of DR4 and DR5, inhibition of survivin, and cleavage of Bid (Fig. 3) . The data also indicated that treatment with the EECR induced activation of caspases-3, -8, and -9 and concomitant proteolytic degradation of PARP and loss of MMP (Fig. 4) . Among the two major apoptotic pathways, the extrinsic pathway requires recruitment of the death receptor-associated death domain and caspase-8/-10, which results in caspase-8/-10 activation and subsequent activation of downstream executioner caspases including caspase-3 and -7 and apoptosis (33, 34) . The intrinsic pathway is triggered by cell stressors and many chemotherapeutic agents, resulting in the induction of mitochondrial dysfunction. Mitochondrial dysfunction induces activation of caspase-9 and subsequently activates effector caspases. Following activation of caspase-3, several specific substrates including PARP are cleaved, eventually leading to apoptosis (30) . In some cells, caspase-8 also mediates the intrinsic pathway via cleavage of the pro-apoptotic Bid protein (8, 9) . In particular, caspases are regulated by various molecules, including members of the Bcl-2 and IAP families. Bcl-2 family proteins are involved in the control of the apoptotic process by interactions between pro-apoptotic (such as Bax and Bad) and anti-apoptotic (such as Bcl-2 and Bcl-xL) members, particularly those of the intrinsic pathway with mitochondrial dysfunction. Cellular proteins in the IAP family (including xIAP, cIAP-1, cIAP-2 and survivin) specifically inhibit caspase-3 and -9 activities, yet they do not inhibit caspase-8 (6,7). In the intrinsic pathway, members of the IAP family bind directly to a principal caspase, such as pro-caspase-3 and -9, and inhibit apoptosis induced by Bcl-2 family proteins. Therefore, the downregulation of IAP family proteins relieves the triggering block of pro-apoptotic signaling and the execution caspases, thus activating cell death (35, 36) . In addition to activation of caspases, EECR treatment resulted in a significant increase in Bax expression and a decrease in Bcl-2 expression (Fig. 3) , suggesting that changes in the ratio of pro-apoptotic and anti-apoptotic Bcl-2 family proteins may contribute to the apoptosis-promoting activity of the EECR. Our results also revealed that pretreatment with the pan-caspase inhibitor, z-VAD-fmk, significantly attenuated EECR-induced apoptosis (Fig. 5) . These data indicate that caspases are the key molecules mediating EECR-induced apoptosis, supporting the hypothesis that the caspase-dependent pathway may be involved in EECR-induced apoptosis of MDA-MB-231 cells.
Accumulating evidence indicates that the redox state of cells is involved in cell fate and suggests the possibility that ROS-mediated oxidative DNA damage and depolarization of mitochondrial membranes play an important role in apoptosis (32, 37) . In the present study, intracellular ROS levels increased markedly within 15 min by EECR treatment in MDA-MB-231 cells; however, the quenching of ROS generation with the antioxidant NAC, a widely used ROS scavenger, did not confer significant protection against EECR-elicited apoptosis, demonstrating that the generation of ROS is not required for apoptosis induced by EECR treatment of MDA-MB-231 cells. In addition to ROS generation, it has been demonstrated that the phosphorylation states of some regulatory proteins are also crucial events along the pathways controlling cell survival and death. Among them, the PI3K/Akt pathway plays an important role controlling the balance between cell survival and apoptosis. This pathway is normally activated in Figure 7 . Effects of an ethanol extract of Cyperus rotundu rhizomes (EECR) treatment on the levels of total and phosphorylated Akt and mitogen activated protein kinase (MAPK) proteins in MDA-MB-231 cells. The cells were treated with 200 µg/ml EECR for the indicated times. The cells were lysed and then equal amounts of cell lysates (30-50 µg) were separated on SDS-polyacrylamide gels and transferred to nitrocellulose membranes. The membranes were probed with the indicated antibodies and the proteins were visualized using an enhanced chemiluminescent detection system. Actin was used as an internal control. a wide variety of cancers and results in enhanced resistance to apoptosis through multiple mechanisms. Therefore, inhibiting PI3K/Akt decreases cell survival and enhances the effects of chemotherapeutic drugs in many types of cancer cells (38, 39) . Another well-established apoptotic signaling cascade is regulated by MAPKs, including JNK, ERK and p38 MAPK. In general, they are activated in response to various stimuli and participate in a variety of signaling pathways that regulate diverse cellular processes including cell growth, differentiation and stress responses (40, 41) . However, PI3K/Akt as well as MAPKs were not activated by EECR treatment, and specific inhibitors of these pathways did not reduce or increase apoptosis. These results demonstrate that activation of PI3K/Akt as well as MAPKs is not a necessary step in EECR-induced apoptosis in MDA-MB-231 cells.
In summary, the results of the present study demonstrate that the death receptor-mediated pathway is initiated by ligation of the transmembrane death receptor to activate membraneproximal caspases (caspase-8), which in turn activate effector caspases such as caspase-3. Second, the mitochondrialmediated pathway requires disruption of the mitochondrial membrane, which induces activation of caspase-9 and thereby initiates the apoptotic caspase cascade. In addition, crosstalk between the two pathways may be mediated by truncation of Bid, which may act as a potential feedback loop to amplify EECR-induced caspase-dependent apoptosis. Although further studies are required to identify the active compounds, these novel phenomena have not been previously described and provide important new insight into the anticancer effects of the EECR. 
